# Testicular Toxicity: Evaluation During Drug Development - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/testicular-toxicity-evaluation-during-drug-development/04182421-d0d9-46c1-ac57-10b10ca62d0c

> FDA guidance document: Testicular Toxicity: Evaluation During Drug Development. Issue date: October 25, 2018. Get complete insights and analysis.

---

## Details

- Title: Testicular Toxicity: Evaluation During Drug Development
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2018-10-25
- Last Changed: 2020-05-05
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2015-D-2306">FDA-2015-D-2306</a>

## Related Documents

- [Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/allergic-rhinitis-developing-drug-products-for-treatment-guidance-for-industry/dcca7128-d84a-436f-83a2-e705904c701f)
- [Nonallergic Rhinitis:  Developing Drug Products for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/nonallergic-rhinitis-developing-drug-products-for-treatment/5453a88f-6b6b-4771-8248-e324727993ad)
- [Migraine: Developing Drugs for Acute Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/migraine-developing-drugs-for-acute-treatment/39ba4b4b-6c93-4849-a087-866c6bf4edff)